Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles-Reference-Cited by-同舟云学术

Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles

Published:2018-12 Issue:1 Volume:17 Page:
ISSN:1476-4598
Container-title:Molecular Cancer
language:en
Short-container-title:Mol Cancer

Author:

Imperial Robin,Ahmed Zaheer,Toor Omer M.,Erdoğan Cihat,Khaliq Ateeq,Case Paul,Case James,Kennedy Kevin,Cummings Lee S.,Melton Niklas,Raza Shahzad,Diri Banu,Mohammad Ramzi,El-Rayes Bassel,Pluard Timothy,Hussain Arif,Subramanian Janakiraman,Masood Ashiq

Funder

U.S. Department of Veterans Affairs

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12943-018-0923-9.pdf

Reference10 articles.

1. Venook AP, Niedzwiecki D, Lenz H-J, et al. CALGB/SWOG 80405: phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC). J Clin Oncol. 2014;32:LBA3. https://doi.org/10.1200/jco.2014.32.18_suppl.lba3 .

2. Hong TS, Clark JW, Haigis KM. Cancers of the Colon and Rectum: identical or fraternal twins? Cancer Discov. 2012;2:117–21. https://doi.org/10.1158/2159-8290.CD-11-0315 .

3. Hu W, Yang Y, Li X, et al. Multi-omics approach reveals distinct differences in left- and right-sided Colon Cancer. Mol Cancer Res. 2018;16:476–85. https://doi.org/10.1158/1541-7786.MCR-17-0483 .